Ondansetron VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Kappa‐opioid agonist VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Mu‐opioid antagonist VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Nalbuphine VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Cromolyn VAS(0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Nicotinamide VAS(0 to 5 cm) · uraemic pruritus
1 finding from 1 review
EPO Duo score(0 to 40) · uraemic pruritus
1 finding from 1 review
Cholestyramine 0 to 3 severity scale · uraemic pruritus
1 finding from 1 review
Smoking cessation · young people
It is very uncertain whether pharmacological interventions changes bupropion vs placebo Smoking cessation compared with placebo (very low certainty).
3 findings from 1 review
RR 1.49 [0.55, 4.02]
1 study · 207 participants
Very low
RR 1.05 [0.41, 2.69]
1 study · 211 participants
Very low
RR 1.11 [0.48, 2.58]
2 studies · 385 participants
Very low
Adverse events (control ‐ placebo) · young people
3 findings from 1 review
no estimate extracted
1 study · 207 participants
Very low
no estimate extracted
1 study · 211 participants
Very low
no estimate extracted
2 studies · 385 participants
Very low
Comparisons and outcomes · young people
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Seizure freedom · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
50% or greater reduction in seizure frequency · people with focal epilepsy
Immunomodulatory interventions probably leads to higher 50% or greater reduction in seizure frequency ‐ ITT analysis compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events of glucocorticoids and immunosuppressive drugs · people with focal epilepsy
Immunomodulatory interventions may leads to higher adverse events of glucocorticoids and immunosuppressive drugs compared with placebo (low certainty).
1 finding from 1 review
Treatment withdrawal · people with focal epilepsy
Immunomodulatory interventions may leads to higher treatment withdrawal compared with placebo (low certainty).
1 finding from 1 review
Allergic reaction · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive effects · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of alcohol misuse 6 months · Parents who use substances
1 finding from 1 review
Frequency of alcohol misuse 12 months · Parents who use substances
1 finding from 1 review